Craig C. Hopkinson Alkermes Plc. (ALKS) insider trading activity

Craig C. Hopkinson is EVP R&D, Chief Medical Officer of Alkermes plc.. Currently has a direct ownership of 65,740 shares of ALKS, which is worth approximately $1.91 Million. The most recent transaction as insider was on Dec 03, 2025, when has been sold 3,748 shares (Ordinary Shares) at a price of $30.0 per share, resulting in proceeds of $112,440. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 65.7K

15.44% 3M change

38.18% 12M change

Total Value Held $1.91 Million

Craig C. Hopkinson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 03 2025	SELL Open market or private sale	$112,440 $30.0 p/Share	3,748 Reduced 5.39%	65,740 Ordinary Shares
Dec 03 2025	BUY Exercise of conversion of derivative security	$72,486 $19.34 p/Share	3,748 Added 5.12%	69,488 Ordinary Shares
Dec 01 2025	SELL Open market or private sale	$117,200 $29.3 p/Share	4,000 Reduced 5.74%	65,740 Ordinary Shares
Nov 03 2025	SELL Open market or private sale	$273,420 $30.38 p/Share	9,000 Reduced 11.43%	69,740 Ordinary Shares
Nov 03 2025	BUY Exercise of conversion of derivative security	$96,700 $19.34 p/Share	5,000 Added 5.97%	78,740 Ordinary Shares
Oct 15 2025	SELL Open market or private sale	$283,770 $31.53 p/Share	9,000 Reduced 10.88%	73,740 Ordinary Shares
Oct 15 2025	BUY Exercise of conversion of derivative security	$96,700 $19.34 p/Share	5,000 Added 5.7%	82,740 Ordinary Shares

Feb 26 2025	SELL Payment of exercise price or tax liability	$106,105 $34.8 p/Share	3,049 Reduced 3.77%	77,740 Ordinary Shares
Feb 26 2025	BUY Exercise of conversion of derivative security	-	6,866 Added 7.83%	80,789 Ordinary Shares
Feb 23 2025	SELL Payment of exercise price or tax liability	$120,582 $35.32 p/Share	3,414 Reduced 4.41%	73,923 Ordinary Shares
Feb 23 2025	BUY Exercise of conversion of derivative security	-	7,689 Added 9.04%	77,337 Ordinary Shares
Feb 22 2025	SELL Payment of exercise price or tax liability	$192,564 $35.32 p/Share	5,452 Reduced 7.26%	69,648 Ordinary Shares
Feb 22 2025	BUY Exercise of conversion of derivative security	-	12,279 Added 14.05%	75,100 Ordinary Shares
Feb 18 2025	SELL Payment of exercise price or tax liability	$141,805 $35.9 p/Share	3,950 Reduced 5.92%	62,821 Ordinary Shares
Feb 18 2025	BUY Exercise of conversion of derivative security	-	8,896 Added 11.76%	66,771 Ordinary Shares
Feb 13 2025	SELL Open market or private sale	$5,057,553 $35.02 p/Share	144,419 Reduced 71.39%	57,875 Ordinary Shares
Feb 13 2025	BUY Exercise of conversion of derivative security	$4,081,280 $28.26 p/Share	144,419 Added 41.65%	202,294 Ordinary Shares
Feb 12 2025	SELL Open market or private sale	$6,758,294 $32.98 p/Share	204,921 Reduced 77.98%	57,875 Ordinary Shares
Feb 12 2025	BUY Exercise of conversion of derivative security	$3,922,169 $19.69 p/Share	199,196 Added 43.12%	262,796 Ordinary Shares
Feb 06 2025	SELL Payment of exercise price or tax liability	$473,455 $31.39 p/Share	15,083 Reduced 19.17%	63,600 Ordinary Shares
Feb 06 2025	BUY Grant, award, or other acquisition	-	34,393 Added 30.42%	78,683 Ordinary Shares
Jan 30 2025	SELL Open market or private sale	$3,234,421 $32.05 p/Share	100,918 Reduced 69.5%	44,290 Ordinary Shares
Jan 30 2025	BUY Exercise of conversion of derivative security	$2,216,246 $22.7 p/Share	97,632 Added 40.2%	145,208 Ordinary Shares
Dec 09 2024	SELL Open market or private sale	$1,961,112 $32.07 p/Share	61,151 Reduced 56.24%	47,576 Ordinary Shares
Dec 09 2024	BUY Exercise of conversion of derivative security	$1,112,231 $22.7 p/Share	48,997 Added 31.07%	108,727 Ordinary Shares

Also insider at

ALBO

ALBIREO PHARMA, INC. Healthcare

Director

CCH